Why Clay Siegall is certain that the Antibody-Drug Conjugate Technology Will Replace Traditional Cancer Therapies

Dr. Clay Siegall is one of the influential figures in the biotech industry. He is renowned for creating a biotech company, Seattle Genetics, that develops treatment drugs for chronic diseases. Since its establishment in 1998, the biotech company, which is headquartered in Seattle, developed over 20 drugs and partnered with companies such as Pfizer, Genentech,…